Literature DB >> 34087384

Effect of hydrophilic and lipophilic statins on early onset cataract: A nationwide case-control study.

Hsiao-Ling Chen1, Hsiu-Mei Chang1, Horng-Jiun Wu2, Ying-Chi Lin3, Yu-Han Chang4, Yong-Chieh Chang1, Wen-Hsien Lee5, Ching-Tang Chang6.   

Abstract

BACKGROUND: Statin is biologically plausible in cataract development, but inconclusive associations between statin and cataract are presented in human studies. Given most early onset cataract (EOC) occurs in regions with high cholesterol composition, we therefore aimed to assess the association between statin and EOC.
METHODS: A population based case-control study was performed using the Taiwan National Health Insurance Research Database (NHIRD). The case involved patients aged 20-55 years with EOC. Controls were 1:1 matched by age, gender, year of index date, and propensity score estimated from comorbidities and comedications. Statin exposure, including intensity, properties and cumulative exposure one year before the index date were tracked. The odds ratios (ORs) of EOC associated with statin were estimated by conditional logistic regression.
RESULTS: A total of 4213 cases and 4213 controls were included. Statins were associated with EOC (OR = 3.257, 95% CI 2.519-4.211). The ORs of cataract was positively associated with cumulative exposure. Subgroup analysis indicated that the ORs of cataract were significant both in lipophilic (OR = 3.485, 95% CI 2.606-4.659) and hydrophilic (OR = 3.241, 95% CI 1.975-5.321) statin users.
CONCLUSIONS: Statins were associated with an increased risk of cataract in young populations.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early onset cataract; Observational study; Statin

Mesh:

Substances:

Year:  2021        PMID: 34087384     DOI: 10.1016/j.yrtph.2021.104970

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  1 in total

1.  Risk Factor Analysis of Early-Onset Cataracts in Taiwan.

Authors:  Lung-Hui Tsai; Ching-Chung Chen; Chien-Ju Lin; Sheng-Pei Lin; Ching-Ying Cheng; Hsi-Pao Hsieh
Journal:  J Clin Med       Date:  2022-04-23       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.